BPC-157 : : ,
When stratified by comparator groups, the pooled estimate was most favorable in monotherapy trials versus placebo (SMD 2.41, 95% CI 4.43 to 0.39), whereas the add-on designs versus the same background treatment (SMD 0.65, 95% CI 1.85 to 0.55), head-to-head comparisons versus another drug (SMD 0.19, 95% CI 0.84 to 0.45), and add-on designs versus placebo (SMD 0.65, 95% CI 1.35 to 0.06) showed more modest estimates and did not provide clear evidence of a between-group difference overall (p=0.21)
Moreover, these drugs also cause multiple side effects, including depressive mood, psychosis, increased irritability, and aggressive behavior (Hixson 2014
Figure 7 3.5.1.3 Theme 3: Pill delivery methods This theme is centered around the various methods and tricks used to successfully administer pilling medication
Wstp GHK-Cu z linii Endogenic to tripeptyd miedziowy kompleks krtkiego peptydu glicylo-L-histydylo-L-lizyny (GHK) ze zwizanym jonem miedzi Cu